AngioDynamics Inc (ANGO)

17.02
0.09 0.53
NASDAQ : Health Care
Prev Close 16.93
Open 16.89
Day Low/High 16.81 / 17.10
52 Wk Low/High 9.71 / 16.99
Volume 203.80K
Avg Volume 259.20K
Exchange NASDAQ
Shares Outstanding 36.42M
Market Cap 625.37M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

AngioDynamics Reaches Analyst Target Price

AngioDynamics Reaches Analyst Target Price

In recent trading, shares of AngioDynamics Inc have crossed above the average analyst 12-month target price of $16.50, changing hands for $16.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AngioDynamics Stock Sees Short Interest Decrease By 32.3%

AngioDynamics Stock Sees Short Interest Decrease By 32.3%

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 314,257 share decrease in total short interest for AngioDynamics Inc , to 659,617, a decrease of 32.27% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

AngioDynamics Reaches Analyst Target Price

AngioDynamics Reaches Analyst Target Price

In recent trading, shares of AngioDynamics Inc have crossed above the average analyst 12-month target price of $15.38, changing hands for $15.49/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AngioDynamics Appoints Michael C. Greiner As New Chief Financial Officer

AngioDynamics Appoints Michael C. Greiner As New Chief Financial Officer

Greiner brings more than 20 years of accounting, corporate finance and operations experience from a variety of global corporations

AngioDynamics (ANGO) Strong On High Relative Volume Today

AngioDynamics (ANGO) Strong On High Relative Volume Today

Trade-Ideas LLC identified AngioDynamics (ANGO) as a strong on high relative volume candidate

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Commit To Buy AngioDynamics At $12.50, Earn 17.2% Annualized Using Options

Commit To Buy AngioDynamics At $12.50, Earn 17.2% Annualized Using Options

Investors considering a purchase of AngioDynamics Inc shares, but cautious about paying the going market price of $13.54/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $12.50 strike, which has a bid at the time of this writing of 75 cents.

AngioDynamics Appoints James C. Clemmer As New President And Chief Executive Officer

AngioDynamics Appoints James C. Clemmer As New President And Chief Executive Officer

Clemmer brings more than 25 years of operational, manufacturing, marketing and business development experience in the global healthcare industry

Commit To Buy AngioDynamics At $10, Earn 17.9% Annualized Using Options

Commit To Buy AngioDynamics At $10, Earn 17.9% Annualized Using Options

Investors considering a purchase of AngioDynamics Inc stock, but cautious about paying the going market price of $11.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $10 strike, which has a bid at the time of this writing of 60 cents.

Oversold Conditions For AngioDynamics (ANGO)

Oversold Conditions For AngioDynamics (ANGO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

FDA Lifts Warning Letters On AngioDynamics' Facilities

FDA Lifts Warning Letters On AngioDynamics' Facilities

Completes Resolution of All Outstanding Warning Letters

Oversold Conditions For AngioDynamics (ANGO)

Oversold Conditions For AngioDynamics (ANGO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.